A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs
Clinical trial NCT07483684 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07483684
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-08-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.